Elizabeth Masson-Hurlburt
2021
In 2021, Elizabeth Masson-Hurlburt earned a total compensation of $1.1M as Executive Vice President and Head of Clinical Operations at CorMedix, a 43% increase compared to previous year.
Compensation breakdown
| Bonus | $37,800 |
|---|---|
| Option Awards | $742,910 |
| Salary | $310,800 |
| Other | $44,818 |
| Total | $1,136,328 |
Masson-Hurlburt received $742.9K in option awards, accounting for 65% of the total pay in 2021.
Masson-Hurlburt also received $37.8K in bonus, $310.8K in salary and $44.8K in other compensation.
Rankings
In 2021, Elizabeth Masson-Hurlburt's compensation ranked 8,345th out of 12,415 executives tracked by ExecPay. In other words, Masson-Hurlburt earned more than 32.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,345 out of 12,415 | 33rd |
Division Manufacturing | 3,692 out of 5,505 | 33rd |
Major group Chemicals And Allied Products | 1,640 out of 2,375 | 31st |
Industry group Drugs | 1,459 out of 2,096 | 30th |
Industry Pharmaceutical Preparations | 1,086 out of 1,546 | 30th |
Source: SEC filing on August 30, 2022.
Masson-Hurlburt's colleagues
We found six more compensation records of executives who worked with Elizabeth Masson-Hurlburt at CorMedix in 2021.
2021
Khoso Baluch
CorMedix
Chief Executive Officer
2021
Thomas Nusbickel
CorMedix
Former Chief Commercial Officer
2021
Phoebe Mounts
CorMedix
General Counsel
2021
Matthew David
CorMedix
Chief Financial Officer
2021
John Armstrong
CorMedix
Former Executive Vice President for Technical Operations
2021
Elizabeth Hurlburt
CorMedix